Scarica l'app Stockscreener
57.08
1.16%
-0.67
Dopo l'orario di chiusura:
57.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$57.75
Aprire:
$57.78
Volume 24 ore:
285.81K
Relative Volume:
0.54
Capitalizzazione di mercato:
$1.78B
Reddito:
$1.29B
Utile/perdita netta:
$131.74M
Rapporto P/E:
13.56
EPS:
4.21
Flusso di cassa netto:
$166.13M
1 W Prestazione:
-1.04%
1M Prestazione:
+0.53%
6M Prestazione:
-22.27%
1 anno Prestazione:
-18.85%
Intervallo 1D:
$56.80
$58.42
Intervallo di 1 settimana:
$54.83
$58.58
Portata 52W:
$46.00
$78.58
Conmed Corp Stock (CNMD) Company Profile
Nome
Conmed Corp
Settore
Industria
Telefono
727-214-2974
Indirizzo
11311 CONCEPT BOULEVARD, LARGO, NY
Confronta CNMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
57.08 | 1.78B | 1.29B | 131.74M | 166.13M | 4.21 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-28 | Downgrade | Stifel | Buy → Hold |
| 2025-02-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-02-01 | Reiterato | Needham | Buy |
| 2023-05-22 | Iniziato | CL King | Buy |
| 2023-03-27 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | Iniziato | Wells Fargo | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2021-10-06 | Aggiornamento | Needham | Hold → Buy |
| 2021-07-15 | Iniziato | UBS | Buy |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2019-11-26 | Downgrade | Needham | Buy → Hold |
| 2019-11-12 | Iniziato | JP Morgan | Overweight |
| 2019-10-31 | Reiterato | Needham | Buy |
| 2019-10-04 | Reiterato | Needham | Buy |
| 2019-08-22 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | Iniziato | Stifel | Buy |
| 2019-04-16 | Reiterato | Needham | Buy |
| 2019-01-23 | Reiterato | Needham | Buy |
| 2018-10-16 | Iniziato | Barclays | Equal Weight |
| 2018-08-07 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-04-26 | Reiterato | Needham | Buy |
| 2018-02-01 | Reiterato | Needham | Buy |
| 2017-07-27 | Reiterato | Needham | Buy |
| 2017-04-27 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | Reiterato | Needham | Buy |
| 2016-11-18 | Reiterato | Needham | Buy |
| 2016-07-28 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | Reiterato | Needham | Buy |
| 2015-10-22 | Reiterato | Northland Capital | Market Perform |
Mostra tutto
Conmed Corp Borsa (CNMD) Ultime notizie
CONMED Co. (NYSE:CNMD) Shares Bought by Brevan Howard Capital Management LP - MarketBeat
Axa S.A. Raises Position in CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED Co. (NYSE:CNMD) Shares Acquired by Dean Capital Management - MarketBeat
ArrowMark Colorado Holdings LLC Decreases Position in CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED (NYSE:CNMD) Rating Lowered to “Hold” at StockNews.com - Defense World
CONMED Co. (NYSE:CNMD) Stock Holdings Raised by First Trust Advisors LP - Defense World
CONMED Co. (NYSE:CNMD) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Dimensional Fund Advisors LP Has $53.07 Million Stock Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Insider Selling: Charles Farkas Sells 4,000 Shares of Conmed Cor - GuruFocus
PDT Partners LLC Sells 13,579 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
Decoding Conmed Corp (CNMD): A Strategic SWOT Insight - GuruFocus
CONMED (NYSE:CNMD) Issues Earnings Results - MarketBeat
CONMED (NYSE:CNMD) Given New $61.00 Price Target at Needham & Company LLC - MarketBeat
JPMorgan Chase & Co. Issues Pessimistic Forecast for CONMED (NYSE:CNMD) Stock Price - Defense World
Earnest Partners LLC Acquires 25,876 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED (NYSE:CNMD) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
CNMD’s 52-Week Rollercoaster: From $46.00 to $78.58 – What’s Next for Investors? - investchronicle.com
Why Conmed (CNMD) is a Top Value Stock for the Long-Term - Yahoo Finance
CONMED Corporation (NYSE:CNMD) Q1 2025 Earnings Call Transcript - Insider Monkey
Conmed (CNMD) Target Price Lowered by Wells Fargo Analyst | CNMD Stock News - GuruFocus
JP Morgan Revises Price Target for Conmed (CNMD) to $58 | CNMD S - GuruFocus
Conmed Corp (CNMD) can make a big difference with a little luck - Sete News
Conmed (CNMD) Analyst Rating Update: Price Target Lowered | CNMD Stock News - GuruFocus
CONMED Corp SEC 10-Q Report - TradingView
Conmed (CNMD) Target Price Adjusted by Analyst Amid Supply Chain - GuruFocus
Conmed (CNMD) Target Price Adjusted by Analyst Amid Supply Chain Challenges | CNMD Stock News - GuruFocus
CNMD Stock Up On Q1 Earnings & Sales Beat, Raised 2025 Outlook - Yahoo Finance
Breaking Down Conmed: 6 Analysts Share Their Views - Benzinga
Conmed (CNMD) Target Price Reduced by Wells Fargo Analyst | CNMD Stock News - GuruFocus
CONMED (CNMD) Reports Strong Q1 Revenue Surpassing Estimates | C - GuruFocus
Conmed: Q1 Earnings Snapshot - MySA
Conmed Corp [CNMD] Insider Activity: An Update for Investors - knoxdaily.com
Conmed Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: ConMed’s Q1 2025 earnings miss EPS forecasts, stock rises - Investing.com
CONMED beats Q1 revenue estimates, raises full-year outlook; shares jump By Investing.com - Investing.com South Africa
CONMED beats Q1 revenue estimates, raises full-year outlook; shares jump - Investing.com Canada
CONMED Q1 2025 slides: Revenue growth continues amid GAAP earnings pressure - Investing.com Canada
CONMED Corporation Announces First Quarter 2025 Financial Results - Stock Titan
CONMED (NYSE:CNMD) Rating Lowered to "Hold" at Stifel Nicolaus - MarketBeat
Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics - Nasdaq
CONMED (NYSE:CNMD) Downgraded by Stifel Nicolaus to “Hold” - Defense World
CONMED (CNMD) Downgraded by Stifel Due to Sales Decline - GuruFocus
What To Expect From CONMED’s (CNMD) Q1 Earnings - Barchart.com
Orthopedic Biomaterial Market Overall Study Report 2025-2032 | - openPR.com
Conmed stock rating cut to hold at Stifel, target drops to $55 - Investing.com Canada
Conmed stock rating cut to hold at Stifel, target drops to $55 By Investing.com - Investing.com South Africa
Conmed (CNMD) Downgraded by Stifel Amid Economic Concerns | CNMD Stock News - GuruFocus
CONMED (NYSE:CNMD) Sets New 1-Year LowWhat's Next? - MarketBeat
Natixis Has $7.80 Million Stock Holdings in CONMED Co. (NYSE:CNMD) - MarketBeat
Fuller & Thaler Asset Management Inc. Takes $59.05 Million Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Barclays PLC Trims Holdings in CONMED Co. (NYSE:CNMD) - MarketBeat
Conmed Corp Azioni (CNMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):